Budget 2023Budget 2023


  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
Budget 2023
Budget 2023

COVID-19: Dr Reddy's expects to launch Sputnik V vaccine in India by March-end

The Russian vaccine is priced at $10 (Rs 720) per shot. If the drugs controller grants approval, the vaccine will become the third to be tried in India after Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin.

January 29, 2021 / 06:45 PM IST
  • bselive
  • nselive
Todays L/H

Dr Reddy’s on January 29 said it is planning to apply for emergency-use approval (EUA) of Sputnik V COVID-19 vaccine by March.

The company said it has completed dosing of the Russian vaccine on about 70 percent participants in the phase-3 bridge trial, and expects to complete the trial in February, following which it will compile the data, and approach the Drug Controller General of India (DCGI) for EUA.

Dr Reddy’s is currently conducting trial on 1,500 volunteers. Sputnik V has to be given in two doses, with 21 days apart from each dose.

“We believe we should be in a position to launch the vaccine through EUA by the end of March,” Deepak Sapra, Chief Executive Officer, API and Pharmaceutical Services, said.